Collection of biospecimens for cardiovascular and metabolic research
Cardiovascular and Metabolic Sciences Biorepository
This study is collecting blood, urine, stool, and heart tissue samples from people with and without heart and metabolic diseases to help researchers learn more about these conditions and improve treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Trial ID | NCT06560424 on ClinicalTrials.gov |
What this trial studies
The Cardiovascular and Metabolic Sciences Biorepository aims to gather and store biospecimens such as blood, urine, stool, and heart tissue from individuals with and without cardiovascular and metabolic diseases. This observational study will create a comprehensive biorepository that facilitates future research into the causes and effects of these diseases. By collecting medical health information alongside biospecimens, the study seeks to enhance the understanding and treatment of cardiovascular and metabolic conditions. The biorepository will also store residual samples from other studies for future research use.
Who should consider this trial
Good fit: Ideal candidates for this study include individuals willing to provide informed consent and who have or do not have cardiovascular or metabolic diseases.
Not a fit: Patients with chronic anemia (hemoglobin consistently <9 g/L) may not benefit from participation in this study.
Why it matters
Potential benefit: If successful, this biorepository could significantly accelerate research into cardiovascular and metabolic diseases, leading to improved diagnosis and treatment options for patients.
How similar studies have performed: Other biorepositories have successfully contributed to advancements in understanding and treating cardiovascular and metabolic diseases, indicating that this approach is both valuable and tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing and able to sign the informed consent document Exclusion Criteria: * Chronic anemia (hemoglobin consistently \<9 g/L)
Where this trial is running
Cleveland, Ohio
- Cleveland Clinic Main Campus — Cleveland, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: W. H. Wilson Tang, MD — The Cleveland Clinic
- Study coordinator: Jennifer Wilcox, BA
- Email: kirsopj@ccf.org
- Phone: 216-636-6153
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.